Home > Market Research > Prescription Medicines > The Pharmaceutical Market: Malaysia

Table of Contents

Management Report
Published: January 2010
Pages: 38
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 595.00   Buy Now!
Research from: Espicom
Sector: Prescription Medicines

Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

The government is keen to encourage the local production of drugs, particularly in the fields of biotechnology and the manufacture of off-patent drugs. Several incentives have been put in place, including tax exemptions for biotech companies that are awarded Bionexus status.

Malaysia’s biotech initiative has begun to attract a growing number of multinational companies investing in the country, there have been rising new and ongoing investments in manufacturing plants and research projects in recent times.

Local manufacturers almost exclusively produce generics and other off-patent medicaments, both ethical and OTC products, but imported medicines by multinational manufacturers still command the lion’s share of the market, at over 70% in value terms.

Highly detailed report content

MARKET OUTLOOK
Key national data projections

Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development

Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property

Pharmaceutical distribution

Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care data, and healthcare personnel.

Top of Page

Table of Contents

EXECUTIVE SUMMARY 1
Introduction 2
Pharmaceutical Market Analysis . 4
Size . 4
Market Structure . 4
Generics Sector 4
OTC Sector . 4
Projections & Outlook . 5
Imports 8
Domestic Manufacturing . 9
Sales Value of Locally Manufactured Pharmaceuticals 10
Government Strategies and Projections for Local Industry 2006-2020 . 10
Strategies 2006-2020 10
Domestic Producers 11
Pharmaniaga . 12
Chemical Company of Malaysia (CCM) Pharmaceuticals 12
Hovid Bhd 12
Carotech Bhd . 13
Multinational Manufacturers 13
Biotechnology 14
Ninebio (9BIO) . 14
Emergent Biosolutions . 14
Inno Biologics 14
Bioven 15
Stemlife 16
Malladi Drugs & Pharmaceutical Ltd 16
Actis Biologics . 16
Saamya Biotech 16
Vivo Bio Tech 16
Other Biotech Developments 17
MDV Loans for Biotech Companies . 17
RM32 Million for Stem Cell Research . 17
CCM Duopharma and Inno Bio Ventures Sign Biosimilars MOU . 17
Exports 18
Research & Development . 18
Pharmaceutical Regulatory Analysis 19
Pharmaceutical Regulation . 19
MALAYSIA PHARMA OUTLOOK
Pharma Outlook espicom BUSINESS INTELLIGENCE
ii Quarter I 2010
Drug Control Authority . 19
National Pharmaceutical Control Bureau . 19
Pharmaceutical Registrations . 20
Priority or Queue System . 21
Licensing . 21
Pharmaceutical Labelling 21
Registration of NCEs . 22
Registration of Generics 22
Registration of Traditional Medicines & OTCs 23
Clinical Trials . 23
MADRAC (ADR reporting) 23
Pricing & Reimbursement . 23
Intellectual Property 23
Pharmaceutical Distribution 24
Distributors 24
Pharmaniaga . 24
Zuellig Pharma 25
Apex Healthcare Berhad . 25
Retailing 26
Healthcare Analysis 26
Demographics . 26
Population . 26
Birth Rate . 27
Death Rate 27
Infant Mortality . 27
Life Expectancy at Birth . 27
Public Health . 27
Causes of Death 27
Incidence of Communicable Diseases . 27
Incidence of Non-communicable Diseases 27
HIV/AIDS . 28
Healthcare System 28
US$55 million National Cancer Institute . 28
Health Expenditure . 28
Ninth Development Plan Allocation (2006-2010) 29
Healthcare Infrastructure 30
Inpatient Analysis 30
Admissions 30
Healthcare Personnel . 32
PHARMA OUTLOOK MALAYSIA
Pharma Outlook espicom BUSINESS INTELLIGENCE
Quarter I 2010 iii
DIRECTORY 33
Government Organisations . 33
Trade Associations . 33
Methodology & Sources . 34
MALAYSIA PHARMA OUTLOOK
Pharma Outlook espicom BUSINESS INTELLIGENCE
iv Quarter I 2010
List of Tables
Key Data Projections, 2010-2015 . 3
Summary of the Malaysian Pharmaceutical Market, 2010 . 4
Market Projections, 2010-2015 . 5
SWOT Analysis of the Malaysian Pharmaceutical Market, 2010 . 6
Espicom Analysis of the Malaysian Pharmaceutical Market, 2010 7
Imports of Pharmaceuticals by Category, 2003-2007 (US$000s) 8
Import Trends (US$000s) . 8
Leading Suppliers of Raw Materials, 2007 (US$000s) . 9
Leading Suppliers of Medicaments, 2007 (US$000s) 9
Sales Value of Locally Manufactured Pharmaceuticals, 1996-2005 . 10
Projections for Pharmaceutical Industry 2006-2020 10
PhAMA Members, 2009 13
Exports of Pharmaceuticals, 2003-2007 (US$000s) . 18
Export Trends (US$000s) . 18
Leading Destinations, 2007 (US$000s) . 18
Drug Registration Fees (Effective 2007) . 20
Drug Applications, 2001-2007 22
Registered Pharmaceutical Products, 2001-2007 22
NCE Applications, 2000-2004 . 22
Licences Issued, 2001-2007 . 24
Pharmaniaga Sales by Product Category, 2003-2005 (US$000s) . 25
Summary of Demographic Data, 2007. 26
Projected Population, 2010-2015 . 26
Healthcare Expenditure, 2006 28
Projected Health Expenditure, 2010-2015 . 29
Government Health Budget Allocation, 2001-2007 (RM millions) . 29
Development Plan Allocation for Health Services, 1996-2010 (RM million) 29
Hospitals & Beds, 2007 30
Government Hospital Admissions, 2000-2007 . 30
Government Hospital Admissions by Type, 2005-2007 . 31
Transplant Facilities by Management and Type, 2006 31
Projected Number of Physicians, 2010-2015 32

For full details, please email keithw@cmsinfo.com

Top of Page

Buy now!

PDF single user

 GBP 595.00   

Paper

 GBP 595.00   

Online Access

 GBP 595.00   

Your personal guarantee

Top of Page